Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/21/25 20:24 | 11/19/25 | ROIV | Health | Drug | Pharmaceutical Preparations | Manchester Keith S | X0 | D | 1 | S | -26,305 | 20.23 | 0 | -1,300 | 18,048 | I | ||||||||||||||||
11/21/25 20:22 | 11/19/25 | ROIV | Health | Drug | Pharmaceutical Preparations | Gold Daniel Allen | X0 | D | 1 | S | -26,305 | 20.23 | 0 | -1,300 | 18,048 | I | ||||||||||||||||
11/21/25 20:15 | 11/19/25 | ROIV | Health | Drug | Pharmaceutical Preparations | Qvt Financial LP | NY | H | Director | 1 | S | -26,305 | 20.23 | 0 | -1,300 | 18,048 | I | |||||||||||||||
11/17/25 17:52 | 11/13/25 | ROIV | Health | Drug | Pharmaceutical Preparations | Ramaswamy Vivek | DC | T | 1 | S.m | -37,939 | 20.46 | 0 | -1,855 | 47,012 | D | ||||||||||||||||
11/7/25 21:00 | 11/7/25 | ROIV | Health | Drug | Pharmaceutical Preparations | Venker Eric | X0 | O | P,Immuno | 10 | M.dm | 85,093 | 12.23 | 0 | 6,958 | 1,505 | D | |||||||||||||||
11/7/25 21:00 | 11/7/25 | ROIV | Health | Drug | Pharmaceutical Preparations | Venker Eric | X0 | O | P,Immuno | 10 | S.dm | -85,093 | 12.23 | 0 | -6,958 | 1,505 | D | |||||||||||||||
9/18/25 19:28 | 9/18/25 | ROIV | Health | Drug | Pharmaceutical Preparations | Gline Matthew | X0 | DO | CEO | 1 | P | 50 | 15.07 | 0 | 3 | 0 | 17,287 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |